Tilray Brands TLRY
NASDAQ TLRY
$4.61 -0.22 (-4.66%)
At close: Aug 20, 2026 · 3:03 PM UTC

Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026)

Tilray Brands' (TLRY) quarterly Amortizatization of Intangibles came in at $19.3 million in Q2 2026, down 43.25% YoY from $34.1 million in Q2 2025, and up 860.8% on a QoQ basis from $2.0 million in Q1 2026.

Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 7 years of Amortizatization of Intangibles data on file, last reported at $19.3 million in Q2 2026.

  • Quarterly Amortizatization of Intangibles fell 43.25% year-over-year to $19.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $38.9 million (down 45.65% YoY) and the FY2026 annual result came in at $67.6 million, down 49.36% from the prior year.
  • Amortizatization of Intangibles rose to $19.3 million in Q2 2026, from $2.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $40.8 million in Q2 2022 to a low of $2.0 million in Q4 2025.
  • A 5-year average of $21.5 million and a median of $29.9 million in 2023 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles slumped 91.51% — and 2024, when it rose 9.44%.
  • Tracing TLRY's Amortizatization of Intangibles over 5 years: stood at $33.3 million in 2022, then slumped by 91.51% to $2.8 million in 2023, then rose by 3.18% to $2.9 million in 2024, then tumbled by 31.89% to $2.0 million in 2025, then soared by 872.89% to $19.3 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $19.3 million (Q2 2026), $2.0 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Tilray Brands 516.11 Mn 281.48 Mn 90.52 Mn 19.34 Mn

Historic Data

Download Data
DateValue
May 31, 2026 19.34 Mn
May 31, 2026 19.34 Mn
Feb 28, 2026 2.01 Mn
Feb 28, 2026 2.01 Mn
Nov 30, 2025 1.99 Mn
Nov 30, 2025 1.99 Mn
Aug 31, 2025 15.56 Mn
Aug 31, 2025 15.56 Mn
May 31, 2025 34.08 Mn
May 31, 2025 34.08 Mn
Feb 28, 2025 2.77 Mn
Feb 28, 2025 2.77 Mn
Nov 30, 2024 2.92 Mn
Nov 30, 2024 2.92 Mn
Aug 31, 2024 31.81 Mn
Aug 31, 2024 31.81 Mn
May 31, 2024 31.73 Mn
May 31, 2024 31.73 Mn
Feb 29, 2024 2.90 Mn
Feb 29, 2024 2.90 Mn